Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Biome Australia Ltd (AU:BIO)
ASX:BIO
Biome Australia Ltd (BIO) Share Price & Analysis
15 Followers
BIO Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.10 - AU$0.73
Previous CloseAU$0.53
Volume453.87K
Average Volume (3M)753.01K
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)AU$5.49M
Total Debt (Recent Filing)AU$467.05K
Price to Earnings (P/E)―
Beta0.52
Next Earnings
Mar 03, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. Volume753,010
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Biome Australia Ltd News
PremiumCompany Announcements
Biome Australia Ltd Celebrates Record Growth
PremiumCompany Announcements
Biome Australia Ltd Completes Share IssuancePremiumCompany Announcements
Biome Australia Ltd Surges Past Sales Forecasts
PremiumCompany Announcements
Biome Australia Bolsters Finances, Plans Strategic GrowthPremiumCompany Announcements
Biome Australia Expands ASX Quotation
PremiumCompany Announcements
Biome Australia Issues Employee Shares, Ensures Compliance
PremiumCompany Announcements
Biome Australia Seeks Quotation for New Securities
PremiumCompany Announcements
Biome Australia Foresees Financial GrowthOptions Prices
Currently, No data available
---
Ownership Overview
11.92% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
88.08% Public Companies and
Individual Investors
BIO FAQ
What was Biome Australia Ltd’s price range in the past 12 months?
Biome Australia Ltd lowest share price was AU$0.10 and its highest was AU$0.73 in the past 12 months.
What is Biome Australia Ltd’s market cap?
Currently, no data Available
When is Biome Australia Ltd’s upcoming earnings report date?
Biome Australia Ltd’s upcoming earnings report date is Mar 03, 2025 which is in 219 days.
How were Biome Australia Ltd’s earnings last quarter?
Currently, no data Available
Is Biome Australia Ltd overvalued?
According to Wall Street analysts Biome Australia Ltd’s price is currently Overvalued.
Does Biome Australia Ltd pay dividends?
Biome Australia Ltd does not currently pay dividends.
What is Biome Australia Ltd’s EPS estimate?
Biome Australia Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Biome Australia Ltd have?
Biome Australia Ltd has 215,390,900 shares outstanding.
What happened to Biome Australia Ltd’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Biome Australia Ltd?
Currently, no hedge funds are holding shares in AU:BIO
---
Biome Australia Ltd Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
452.63%
12-Months-Change
Fundamentals
Return on Equity
-82.81%
Trailing 12-Months
Asset Growth
-7.96%
Trailing 12-Months
Company Description
Biome Australia Ltd
Biome Australia Ltd licences, develops, and markets evidence-based, complementary medicines, including nutraceuticals food-based vitamins and weight management products and live biotherapeutics. The firm owns brands namely; Activated Nutrients: a range of completely organic, plant-based, all-in-one nutritional products; Activated Probiotics: a first-of-its-kind range of clinically-backed precision probiotics; and AXP TM, a certified range of performance products for athletes. Domestically it caters to Australia and In international markets, the Group distributes and markets its Activated Probiotics range in the United Kingdom and New Zealand through independent health practitioners. Key revenue is derived from domestic sales.
---
Technical Analysis
---